Mobile Cardiovascular Risk Service Trial
NCT03081871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2018-10-11
Summary
Risk factors for cardiovascular disease are poorly controlled even for patients who frequently visit their physician, leading to large numbers of preventable cardiovascular events such as heart attacks and strokes. Research from integrated healthcare systems suggests that risk factors can be controlled better and treatment strategies for cardiovascular disease can be markedly improved by using a centralized cardiovascular risk service (CVRS) managed by pharmacists. The investigators are confident that a pharmacist-managed mHealth CVRS can become a strategy in un-integrated healthcare settings to markedly reduce cardiovascular events in the United States.
Conditions
- Cardiovascular Diseases
- Personal Health Records
- Pharmaceutical Care
- Mobile Apps
Interventions
- OTHER
-
Pharmacist-led cardiovascular risk service (CVRS)
CVRS pharmacists will access the study database including patient baseline information obtained from the medical record and patient entered data to make their assessments and recommendations to onsite physicians and onsite clinical pharmacists and individualize their communication with patients. The intervention will provide patient-centered counseling and education to improve medication adherence, lifestyle modifications and/or smoking cessation. The CVRS pharmacist does not make changes to therapy independently but, rather, provides the physicians and on-site pharmacists with action plans and status updates about adherence to Guideline metrics, which should markedly reduce the gaps in guideline-concordant therapy that place patients at risk for CVD events.
- OTHER
-
Mobile access to study Personal Health Record
Only subjects assigned to the intervention arm will have access to the mobile app version of the study personal Health Record.
- OTHER
-
Web access to study Personal Health Record
Subjects assigned to both the intervention and control arms will have access to the standard website version of the study personal Health Record.
Sponsors & Collaborators
-
University of Iowa
lead OTHER
Principal Investigators
-
Elizabeth Chrischilles, PhD · University of Iowa
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-01
- Primary Completion
- 2018-08-31
- Completion
- 2018-08-31
Countries
- United States
Study Locations
More Related Trials
-
Preventing Adverse Drug Events With PatientSite
NCT00140504 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Habit-based Work-up to Support Medication Adherence
NCT06230978 ·Status: COMPLETED ·Phase: NA
-
Improving Medication Use in Patients With Hypertension
NCT00388817 ·Status: COMPLETED ·Phase: NA
-
Mobile Health Technology for Chronic Kidney Disease Patients: Medication Management
NCT02905474 ·Status: COMPLETED ·Phase: NA
-
Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
NCT00632021 ·Status: COMPLETED ·Phase: NA
-
Electronic Medication Adherence Reporting and Feedback During Care Transitions
NCT03475030 ·Status: COMPLETED ·Phase: NA
-
SystemCHANGE™ Intervention on Medication Adherence in Older Adults With Heart Failure
NCT03162848 ·Status: COMPLETED ·Phase: NA
-
Medication Adherence Clinical Decision Support
NCT03748420 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial of Enhanced Pharmacy Care in Older Veteran Outpatients
NCT00122122 ·Status: COMPLETED ·Phase: PHASE3
-
Personal Health Records and Elder Medication Use Quality
NCT02012712 ·Status: COMPLETED ·Phase: NA
-
Alleviating Geriatric Inpatients' Medication-related Iatrogenesis
NCT05017948 ·Status: COMPLETED ·Phase: NA
-
Testing the Impact of Pre-visit Priming for Medications
NCT07281131 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
NCT05351749 ·Status: COMPLETED ·Phase: NA
-
Impact of Vendor Systems on Ambulatory Medication Safety
NCT00773500 ·Status: COMPLETED
-
Myocardial Infarction Prescription Duration Adherence Study
NCT03257579 ·Status: COMPLETED ·Phase: NA
-
Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services
NCT02752997 ·Status: COMPLETED ·Phase: NA
-
A Pharmacist-Led Education Program to Improve Adherence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation
NCT07159399 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication
NCT01684176 ·Status: COMPLETED ·Phase: NA
-
Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care
NCT01164137 ·Status: COMPLETED ·Phase: NA
-
Pharmacist Enhanced Service for Cardiovascular Risk Reduction
NCT04220788 ·Status: WITHDRAWN ·Phase: NA
-
Trial of a Pharmacist-physician Intervention Model to Reduce High-risk Drug Use by Hospitalised Elderly Patients
NCT02570945 ·Status: COMPLETED ·Phase: PHASE4
-
Reducing Injuries From Medication-Related Falls Using Computerized Alerts for High Risk Patients
NCT00818285 ·Status: COMPLETED ·Phase: NA
-
Fixed-Dose Combinations Pragmatic Randomized Implementation Trial for Blood Pressure Control
NCT07228065 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Interactive Medication Reconciliation By Secure Messaging
NCT01564446 ·Status: UNKNOWN ·Phase: PHASE1
-
Smart Blister Packaging and Mobile Application to Monitor and Support Medication Adherence: a Two-arm Usability Study
NCT07099612 ·Status: COMPLETED ·Phase: NA